Search Filters

HTA of repatriation of paediatric haematopoietic stem cell transplant services to Ireland

Status: Published on

HIQA has started work on a Health Technology Assessment (HTA) of the repatriation of paediatric allogeneic haematopoietic stem cell transplant services.

Allogeneic haematopoietic stem cell transplant (HSCT), sometimes known as a bone marrow transplant (BMT), is the internationally recognised standard of care for children with certain inborn errors of metabolism, inborn errors of immunity and haemoglobinopathies. While HSCT is available in Ireland to children with bone marrow failure syndromes or haematological malignancies, children with these other conditions requiring HSCT must travel abroad to avail of this treatment.

This assessment was requested by the National Paediatric Public Health Lead in the Health Service Executive (HSE), with support from specialist clinicians in Children’s Health Ireland.

  • Read the protocol